On 26 August 2026, MicroPort CardioFlow Medtech Corporation released an updated list of its nine‐member Board of Directors and detailed their respective roles across five Board committees.

The Board is led by Dr. Brian Chang, Non-executive Director and Chairman. Executive leadership comprises Mr. Chen Guoming (Chief Executive Officer), Mr. Zhang Ruinian (President) and Mr. Philippe Wanstok. Mr. Deng Aoyi serves as a Non-executive Director, while independent oversight is provided by Mr. Jonathan H. Chou, Ms. Sun Zhixiang, Dr. Hu Bingshan and Mr. Mao Junxiang.

Committee structure and leadership are as follows: • Audit Committee – chaired by Independent Non-executive Director Mr. Jonathan H. Chou. • Remuneration Committee – chaired by Independent Non-executive Director Dr. Hu Bingshan. • Nomination Committee – chaired by CEO Mr. Chen Guoming. • Strategy Committee – chaired by Board Chairman Dr. Brian Chang. • Commercialization Committee – chaired by Independent Non-executive Director Ms. Sun Zhixiang.

All directors hold at least one committee membership, indicating full Board engagement in governance, strategic planning and oversight functions. The announcement underscores MicroPort CardioFlow’s commitment to clear governance structures and defined leadership responsibilities.